from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0288/esxH

LFCtreatmentdescriptionclass of inhibitor

-2.355

Amikacinug/mL Amikacintranslation

-2.829

Cap5-10ug/mL Capreomycintranslation

-3.117

Rox10-50 ug/mL Roxithromycintranslation

-1.227

SM2-5 ug/mL Streptomycintranslation

-1.842

Tet5-10 ug/mL Tetracyclinetranslation

-0.955

Rif0.2-5ug/mL Rifampicintranscription

-1.174

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.015

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.354

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.130

CPZ10-50 ug/mL Chlorpromazinerespiration

1.973

Clofazimine10-13 ug/mL Clofaziminerespiration

0.038

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.267

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.418

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.615

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.090

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.804

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.020

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.307

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.115

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.520

KCN5-20 ug/mL Potassium cyaniderespiration

0.019

NaN30.2-2 mM Sodium aziderespiration

-0.228

Nigericin50 uM Nigericinrespiration

0.041

TRC10-150 ug/mL Triclosanrespiration

-0.148

TRZ10-25 ug/mL Thioridazinerespiration

-1.410

Valinomycin0.5-10 uM Valinomycinrespiration

-0.896

ZnSO42 mM ZnSO4respiration

-0.541

menadione6-10 ug/mL Menadionerespiration

1.935

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

1.546

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.979

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.571

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.302

NRP_1Non-replicating persistence stage 1dosRassociated

0.465

Amp0.2mg/mL AmpicillincellWall

0.374

Cephalexin20-100 ug/mL CephalexincellWall

0.655

Cerulenin0.32-5 ug/mL CerulenincellWall

0.883

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.943

EMB10-20 ug/mL EthambutolcellWall

0.511

Eta12-40 ug/mL EthionamidecellWall

0.845

INH0.2-0.4 ug/mL IsoniazidcellWall

0.392

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.365

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.191

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.412

BZA0.12 mg/mL BenzamidearomaticAmides

-0.227

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.099

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.313

H2O24 mM hydrogen peroxideDNAdamaging

-1.542

Levo10 ug/mL LevofloxacinDNAdamaging

0.358

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.121

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.299

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.142

UVUV-irradiationDNAdamaging

-0.011

ARP41-4 ug/mL Antitubercular compound ARP4?

0.385

Antimycin12.5-50 ug/mL Antimycin A?

0.163

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.393

PA_110-50 ug/mL Antitubercular compound PA-1?

0.257

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.052

PA8240.2-2 ug/mL PA-824?

-0.892

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.132

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.166

Verapamil50 uM Verapamil?

0.241

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.162

methoxatin10-20 ug/mL Methoxatin?